4th World Congress on Precision and Personalized Medicine

4th World Congress on Precision and Personalized Medicine

November 27 – 28 | Zurich, Switzerland

This global meeting will convene researchers, clinicians, policymakers, and industry leaders to advance innovation in precision and personalized healthcare. With the theme “Precision Medicine: Pioneering Healthcare Breakthroughs for a Healthier Future,” the program spans genomics, pharmacogenomics, biomarkers, targeted therapies, AI, digital health, and clinical implementation. Attendees can expect cutting-edge science, workshops, exhibitions, and networking focused on translating discoveries into transformative patient care.

To learn more, visit the conference webpage. Please note: Registration is required.

Integrating Genetics into the Tanzanian Healthcare: An Overview

Integrating Genetics into the Tanzanian Healthcare: An Overview

Tuesday, May 28 | 9 a.m. ET | Virtual

Speaker: Dr. Mohamed Zahir Alimohamed

Dr. Alimohamed will provide an overview of the current landscape and future prospects of integrating genetics into healthcare practices in Tanzania, beginning by outlining the existing healthcare infrastructure and genetic services available in the country. Next, Dr. Alimohamed will discuss the challenges and opportunities faced in implementing genetic testing, counseling, and treatment options within the Tanzanian healthcare system.

To learn more and register, visit the GGMC Educational Webinar Series webpage.

Please note: Registration is required for this webinar.

Clinical, technical, and environmental biases influencing equitable access to clinical genetics/genomics testing: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG)

Posted on by Alexis
Dena R Matalon, Cinthya J Zepeda-Mendoza, Mahmoud Aarabi, Kaitlyn Brown, Stephanie M Fullerton, Shagun Kaur, Fabiola Quintero-Rivera, Matteo Vatta; ACMG Social, Ethical and Legal Issues Committee and the ACMG Diversity, Equity and Inclusion Committee

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants

Posted on by Alexis

Chad A Bousman, James M Stevenson, Laura B Ramsey, Katrin Sangkuhl, J Kevin Hicks, Jeffrey R Strawn, Ajeet B Singh, Gualberto Ruaño, Daniel J Mueller, Evangelia Eirini Tsermpini, Jacob T Brown, Gillian C Bell, J Steven Leeder, Andrea Gaedigk, Stuart A Scott, Teri E Klein, Kelly E Caudle, Jeffrey R Bishop

Healthcare Professionals’ Genomics Education Week

Monday, June 5 – Friday, June 9 | Online

Genomics is becoming an increasingly important part of patient care, but healthcare providers may not be aware of genomics education resources that are available. The National Human Genome Research Institute and its partners are organizing a social media campaign from June 5 to June 9, 2023, that focuses on healthcare provider genomics education. This initiative will include panel discussions, webinars, Twitter chats and Q&As.

Follow on Twitter: #MedGeneEd23

Themes:

Visit the NHGRI website for a detailed schedule of presentations.

DPYD Testing: Time to Put Patient Safety First

Posted on by Alexis

Sharyn D Baker, Susan E Bates, Gabriel A Brooks, William L Dahut, Robert B Diasio, Wafik S El-Deiry, William E Evans, William D Figg, Dan L Hertz, J Kevin Hicks, Suneel Kamath, Pashtoon Murtaza Kasi, Todd C Knepper, Howard L McLeod, Peter H O’Donnell, Mary V Relling, Michelle A Rudek, Tristan M Sissung, D Max Smith, Alex Sparreboom, Sandra M Swain, Christine M Walko

Beyond the Medical: Genetic Testing for Social Traits Virtual Seminar

Friday, December 9 | 12-1 p.m. ET | Virtual

Anya Prince, JD and Jean Cadigan, PhD will give a talk “Beyond the Medical: Genetic Testing for Social Traits.”

In traditional predictive genetic testing, single gene variants are analyzed to determine whether individuals are at high risk of developing disease. The vast majority of diseases, however, are polygenic—caused by many different genes. Polygenic risk scores (PRS) hold promise to predict risk for complex diseases like heart disease or diabetes by measuring the contribution of hundreds of genetic variants at once. Yet beyond prediction of medical outcomes, the realm of ‘sociogenomics’ is developing polygenic scores (PGS) measuring genetic contributions to social traits and behavioral factors, such as income, educational attainment, sexuality, and optimism. This presentation will present initial findings of a newly-funded NIH grant to study these complex scores.

Sponsor: UNC Center for Genomics & Society

Register: https://zoom.us/webinar/register/WN_5i2AoI6HSHiQmmEjGYNtjw

Center for Genomics & Society at UNC Chapel Hill Logo